---
title: "Beijing Hotgen Biotech Co., Ltd (688068.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688068.SH.md"
symbol: "688068.SH"
name: "Beijing Hotgen Biotech Co., Ltd"
industry: "Life Sciences Tools and Services"
datetime: "2026-05-19T23:08:52.432Z"
locales:
  - [en](https://longbridge.com/en/quote/688068.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688068.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688068.SH.md)
---

# Beijing Hotgen Biotech Co., Ltd (688068.SH)

## Company Overview

Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers public safety solutions such as drug tasting, customs disease control, bioterrorism and food safety solutions. The company also provides clinical diagnostics and product solutions, including upconversion light, chemiluminescence, sugar capture, microfluidics, and genetic testing for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, microorganisms, and mycotoxins.

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | CN Market |
| Website | [www.hotgen.com.cn](https://www.hotgen.com.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:08.000Z

**Overall: D (0.62)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 23 / 25 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -12.17% |  |
| Net Profit YoY | 0.61% |  |
| P/B Ratio | 3.54 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 8612679116.87 |  |
| Revenue | 427252638.76 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -9.11% | D |
| Profit Margin | -57.69% | E |
| Gross Margin | 52.50% | B |
| Revenue YoY | -12.17% | E |
| Net Profit YoY | 0.61% | C |
| Total Assets YoY | -5.52% | D |
| Net Assets YoY | -13.10% | E |
| Cash Flow Margin | 54.29% | C |
| OCF YoY | -12.17% | E |
| Turnover | 0.13 | E |
| Gearing Ratio | 16.16% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Beijing Hotgen Biotech Co., Ltd",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-12.17%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "0.61%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.54",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "8612679116.87",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "427252638.76",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-9.11%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-57.69%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "52.50%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "-12.17%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "0.61%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "-5.52%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-13.10%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "54.29%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "-12.17%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.13",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "16.16%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -34.87 | 22/25 | - | - | - |
| PB | 3.54 | 15/25 | 5.88 | 5.04 | 4.18 |
| PS (TTM) | 20.12 | 27/25 | 37.34 | 33.00 | 26.22 |
| Dividend Yield | 0.00% | - | 0.15% | 0.14% | 0.13% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | WuXi AppTec (603259.SH) | A | A | C | A | B | B |
| 02 | Pharmaron (300759.SZ) | B | B | C | B | B | B |
| 03 | Chemexpress (688131.SH) | B | B | C | C | B | B |
| 04 | HitGen (688222.SH) | B | A | D | B | C | B |
| 05 | GEMPHARMATECH (688046.SH) | B | B | D | A | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688068.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688068.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688068.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/688068.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**